id	sid	eid	entity	type
admet-2603	1	1	5-fluorouracil	QUANTITY
admet-2603	1	2	https://doi.org/10.5599/admet.2603 1 admet &	ORG
admet-2603	1	3	13(1	CARDINAL
admet-2603	1	4	2025	CARDINAL
admet-2603	1	5	2603	CARDINAL
admet-2603	1	6	issn	PERSON
admet-2603	1	7	1848-7718	DATE
admet-2603	1	8	shiori ishida1	PERSON
admet-2603	1	9	samuel lee2	PERSON
admet-2603	1	10	karl box2	PERSON
admet-2603	1	11	kiyohiko sugano1	PERSON
admet-2603	1	12	1molecular	CARDINAL
admet-2603	1	13	1	CARDINAL
admet-2603	1	14	noji-higashi	PERSON
admet-2603	1	15	kusatsu	PERSON
admet-2603	1	16	525-8577	CARDINAL
admet-2603	1	17	japan 2pion inc.	ORG
admet-2603	1	18	uk) ltd.	ORG
admet-2603	1	19	east sussex	GPE
admet-2603	1	20	rh18 5dw	PRODUCT
admet-2603	1	21	united kingdom *	GPE
admet-2603	2	1	561	CARDINAL
admet-2603	2	2	december 1, 2024	DATE
admet-2603	2	3	january 14, 2025	DATE
admet-2603	2	4	january 18, 2025	DATE
admet-2603	5	1	(pion inc.	ORG
admet-2603	7	1	10 %	PERCENT
admet-2603	8	1	6.5	CARDINAL
admet-2603	8	2	10 mm	QUANTITY
admet-2603	8	3	)=	ORG
admet-2603	8	4	4.4 mm	QUANTITY
admet-2603	9	1	8 mm	QUANTITY
admet-2603	10	1	less than 0.1	CARDINAL
admet-2603	10	2	120 min	DATE
admet-2603	11	1	ketoprofen	GPE
admet-2603	11	2	naproxen	ORG
admet-2603	15	1	2025	CARDINAL
admet-2603	19	1	1	CARDINAL
admet-2603	20	1	approximately ph 6.5	CARDINAL
admet-2603	20	2	2,3	CARDINAL
admet-2603	21	1	discovery	PRODUCT
admet-2603	21	2	4	CARDINAL
admet-2603	22	1	the past two decades	DATE
admet-2603	25	1	5	CARDINAL
admet-2603	26	1	https://doi.org/10.5599/admet.2603 https://doi.org/10.5599/admet.2603	PERSON
admet-2603	27	1	s. ishida et al	PERSON
admet-2603	27	2	13(1	CARDINAL
admet-2603	27	3	2025	CARDINAL
admet-2603	27	4	2603	CARDINAL
admet-2603	27	5	4	CARDINAL
admet-2603	29	1	9	CARDINAL
admet-2603	30	1	9	CARDINAL
admet-2603	31	1	10	CARDINAL
admet-2603	31	2	11	CARDINAL
admet-2603	32	1	12,13	CARDINAL
admet-2603	33	1	1	CARDINAL
admet-2603	34	1	5,12-17	CARDINAL
admet-2603	35	1	18,19	CARDINAL
admet-2603	36	1	higher than 6.5	CARDINAL
admet-2603	36	2	6.05	CARDINAL
admet-2603	36	3	6.69	CARDINAL
admet-2603	36	4	37 °	QUANTITY
admet-2603	36	5	0.15	CARDINAL
admet-2603	37	1	20	CARDINAL
admet-2603	38	1	18,19	CARDINAL
admet-2603	41	1	5,12-15	CARDINAL
admet-2603	44	1	19	CARDINAL
admet-2603	45	1	17	CARDINAL
admet-2603	47	1	19,22	CARDINAL
admet-2603	49	1	11,23-25	CARDINAL
admet-2603	52	1	three	CARDINAL
admet-2603	52	2	three	CARDINAL
admet-2603	52	3	two	CARDINAL
admet-2603	52	4	1	CARDINAL
admet-2603	53	1	(pion inc.	ORG
admet-2603	54	1	1	CARDINAL
admet-2603	55	1	9	CARDINAL
admet-2603	56	1	6.5	CARDINAL
admet-2603	56	2	10 mm	QUANTITY
admet-2603	56	3	0.14	CARDINAL
admet-2603	57	1	2,3	CARDINAL
admet-2603	59	1	pampa	ORG
admet-2603	60	1	26,27	CARDINAL
admet-2603	61	1	1	CARDINAL
admet-2603	61	2	13(1	CARDINAL
admet-2603	61	3	2025	CARDINAL
admet-2603	61	4	2603	CARDINAL
admet-2603	61	5	3	CARDINAL
admet-2603	61	6	1	CARDINAL
admet-2603	61	7	log poct	PERSON
admet-2603	61	8	10-6 cm2	QUANTITY
admet-2603	61	9	188	CARDINAL
admet-2603	61	10	9.23 280	CARDINAL
admet-2603	61	11	194 -0.01 -0.01	QUANTITY
admet-2603	61	12	9.10 290	CARDINAL
admet-2603	61	13	331	CARDINAL
admet-2603	61	14	7.15 330	CARDINAL
admet-2603	61	15	254	CARDINAL
admet-2603	61	16	3.16 4.00	CARDINAL
admet-2603	61	17	280	CARDINAL
admet-2603	61	18	267 1.95 9.24	MONEY
admet-2603	61	19	7.87 276	CARDINAL
admet-2603	61	20	230 3.24 4.14	CARDINAL
admet-2603	61	21	0.88 8.42 320	QUANTITY
admet-2603	61	22	235	CARDINAL
admet-2603	61	23	1.49 9.01	CARDINAL
admet-2603	61	24	8.34 310	CARDINAL
admet-2603	61	25	259	CARDINAL
admet-2603	61	26	0.82 7.98 320	MONEY
admet-2603	62	1	20	CARDINAL
admet-2603	62	2	0.15	CARDINAL
admet-2603	62	3	37 °	QUANTITY
admet-2603	62	4	25 °	QUANTITY
admet-2603	63	1	0.15 m	QUANTITY
admet-2603	64	1	28	CARDINAL
admet-2603	65	1	6.5	CARDINAL
admet-2603	66	1	37 °	QUANTITY
admet-2603	66	2	22.2 mm	QUANTITY
admet-2603	66	3	7.0 mm	QUANTITY
admet-2603	66	4	3 mm	QUANTITY
admet-2603	67	1	0.1 mm	QUANTITY
admet-2603	68	1	tsuji oil mills co., ltd (mie	ORG
admet-2603	68	2	japan	GPE
admet-2603	68	3	24 to 32 %	PERCENT
admet-2603	68	4	20 to 28 %	PERCENT
admet-2603	68	5	12 to 20 %	PERCENT
admet-2603	68	6	8 to 15 %	PERCENT
admet-2603	68	7	1 to 5 %	PERCENT
admet-2603	69	1	antipyrine	ORG
admet-2603	69	2	ketoprofen	GPE
admet-2603	69	3	naproxen	ORG
admet-2603	69	4	8	CARDINAL
admet-2603	69	5	6	CARDINAL
admet-2603	69	6	osaka	GPE
admet-2603	69	7	japan	GPE
admet-2603	70	1	tokyo	GPE
admet-2603	70	2	osaka	GPE
admet-2603	70	3	japan	GPE
admet-2603	71	1	cambridge	GPE
admet-2603	71	2	ma, usa	ORG
admet-2603	72	1	μflux	GPE
admet-2603	72	2	(pion inc.	ORG
admet-2603	72	3	billerica	GPE
admet-2603	72	4	01821	DATE
admet-2603	72	5	25	CARDINAL
admet-2603	72	6	10 %	PERCENT
admet-2603	72	7	30	CARDINAL
admet-2603	73	1	19.6 ml	QUANTITY
admet-2603	73	2	10.1 mm	QUANTITY
admet-2603	73	3	0.13	CARDINAL
admet-2603	74	1	hcl	PERSON
admet-2603	74	2	0.4 ml	QUANTITY
admet-2603	74	3	0.17	CARDINAL
admet-2603	74	4	6.5	CARDINAL
admet-2603	74	5	10 mm	QUANTITY
admet-2603	74	6	4.4 mm	QUANTITY
admet-2603	74	7	0.14	CARDINAL
admet-2603	75	1	31	CARDINAL
admet-2603	75	2	second	ORDINAL
admet-2603	75	3	1	CARDINAL
admet-2603	76	1	37 °	QUANTITY
admet-2603	77	1	150	CARDINAL
admet-2603	78	1	1	CARDINAL
admet-2603	79	1	300	CARDINAL
admet-2603	79	2	kyoto	GPE
admet-2603	79	3	japan	GPE
admet-2603	81	1	6.5	CARDINAL
admet-2603	83	1	98 ml	QUANTITY
admet-2603	83	2	10.1 mm	QUANTITY
admet-2603	83	3	0.13	CARDINAL
admet-2603	83	4	100 ml	QUANTITY
admet-2603	84	1	hcl	PERSON
admet-2603	84	2	2 ml	QUANTITY
admet-2603	84	3	0.17	CARDINAL
admet-2603	84	4	6.5	CARDINAL
admet-2603	84	5	10 mm	QUANTITY
admet-2603	85	1	4.4 mm	QUANTITY
admet-2603	85	2	0.14	CARDINAL
admet-2603	86	1	6.5	CARDINAL
admet-2603	86	2	1	CARDINAL
admet-2603	86	3	1	CARDINAL
admet-2603	87	1	init	ORG
admet-2603	87	2	2	CARDINAL
admet-2603	89	1	100 ml	QUANTITY
admet-2603	89	2	95 %	PERCENT
admet-2603	90	1	20 ml	QUANTITY
admet-2603	90	2	20 ml	QUANTITY
admet-2603	91	1	https://doi.org/10.5599/admet.2603 s. ishida et al	PERSON
admet-2603	91	2	13(1	CARDINAL
admet-2603	91	3	2025	CARDINAL
admet-2603	91	4	2603	CARDINAL
admet-2603	91	5	4	CARDINAL
admet-2603	92	1	8 mm	QUANTITY
admet-2603	92	2	4.4 mm	QUANTITY
admet-2603	92	3	0.14	CARDINAL
admet-2603	93	1	37 °	QUANTITY
admet-2603	94	1	150	CARDINAL
admet-2603	95	1	2 and 20 mm	QUANTITY
admet-2603	95	2	1	CARDINAL
admet-2603	97	1	30	CARDINAL
admet-2603	100	1	first	ORDINAL
admet-2603	100	2	1	CARDINAL
admet-2603	101	1	2	CARDINAL
admet-2603	102	1	60 min	TIME
admet-2603	102	2	less than 0.1	CARDINAL
admet-2603	102	3	120 min	DATE
admet-2603	103	1	μflux	GPE
admet-2603	106	1	2	CARDINAL
admet-2603	107	1	± s.d.	GPE
admet-2603	107	2	3	CARDINAL
admet-2603	108	1	6.5 ±	CARDINAL
admet-2603	108	2	120 min	QUANTITY
admet-2603	108	3	6.5 ± 0.1	QUANTITY
admet-2603	108	4	2	CARDINAL
admet-2603	109	1	ketoprofen	GPE
admet-2603	109	2	naproxen	ORG
admet-2603	109	3	6.5	CARDINAL
admet-2603	109	4	0	CARDINAL
admet-2603	109	5	3	CARDINAL
admet-2603	110	1	4c	CARDINAL
admet-2603	111	1	5	CARDINAL
admet-2603	112	1	6.5	CARDINAL
admet-2603	112	2	4a	CARDINAL
admet-2603	112	3	4b	CARDINAL
admet-2603	115	1	3	CARDINAL
admet-2603	116	1	± s.d.	GPE
admet-2603	116	2	3	CARDINAL
admet-2603	117	1	io n	FAC
admet-2603	117	2	io n	FAC
admet-2603	117	3	m l-1 admet &	ORG
admet-2603	117	4	13(1	CARDINAL
admet-2603	117	5	2025	CARDINAL
admet-2603	117	6	2603	CARDINAL
admet-2603	117	7	5	CARDINAL
admet-2603	117	8	4	CARDINAL
admet-2603	118	1	± s.d.	GPE
admet-2603	118	2	3	CARDINAL
admet-2603	118	3	5	CARDINAL
admet-2603	119	1	± s.d.	GPE
admet-2603	119	2	3	CARDINAL
admet-2603	119	3	2	CARDINAL
admet-2603	119	4	init	ORG
admet-2603	119	5	10-6 cm	QUANTITY
admet-2603	119	6	120 min	QUANTITY
admet-2603	119	7	1.27 ±	MONEY
admet-2603	119	8	6.50 ± 0.01	MONEY
admet-2603	119	9	5.0 mg/ml	QUANTITY
admet-2603	119	10	1.17 ±	MONEY
admet-2603	119	11	3.54 ±	QUANTITY
admet-2603	119	12	6.48 ± 0.00	MONEY
admet-2603	119	13	10 mg/ml	QUANTITY
admet-2603	119	14	1.97 ±	MONEY
admet-2603	119	15	ketoprofen	GPE
admet-2603	119	16	0.465 ±	MONEY
admet-2603	119	17	1.0 mg/ml	QUANTITY
admet-2603	119	18	0.280 ±	MONEY
admet-2603	119	19	0.889 ±	MONEY
admet-2603	119	20	14.8 ±	MONEY
admet-2603	119	21	1.0 mg/ml	QUANTITY
admet-2603	119	22	14.4 ±	MONEY
admet-2603	119	23	6.59 ± 0.00	QUANTITY
admet-2603	119	24	14.7 ± 0.5	MONEY
admet-2603	119	25	1.0 mg/ml	QUANTITY
admet-2603	119	26	10.8 ±	QUANTITY
admet-2603	119	27	6.63 ± 0.01	QUANTITY
admet-2603	119	28	0.594 ±	MONEY
admet-2603	119	29	6.46 ±	QUANTITY
admet-2603	119	30	6.46 ± 0.00	QUANTITY
admet-2603	119	31	10 mg/ml	QUANTITY
admet-2603	119	32	0.594 ±	MONEY
admet-2603	119	33	1.22 ±	MONEY
admet-2603	119	34	43.5 ±	QUANTITY
admet-2603	119	35	6.46 ± 0.01	MONEY
admet-2603	119	36	0.5 mg/ml	QUANTITY
admet-2603	119	37	6.56 ±	QUANTITY
admet-2603	119	38	3	CARDINAL
admet-2603	120	1	first	ORDINAL
admet-2603	120	2	ketoprofen	GPE
admet-2603	120	3	naproxen	ORG
admet-2603	120	4	6.5	CARDINAL
admet-2603	120	5	0	CARDINAL
admet-2603	121	1	1/	CARDINAL
admet-2603	121	2	1/	CARDINAL
admet-2603	123	1	150	CARDINAL
admet-2603	123	2	164 μm	QUANTITY
admet-2603	123	3	pion inc.	ORG
admet-2603	123	4	1	CARDINAL
admet-2603	128	1	io n	FAC
admet-2603	128	2	io n	FAC
admet-2603	128	3	io n	FAC
admet-2603	128	4	io n	FAC
admet-2603	128	5	io n	FAC
admet-2603	128	6	l-1 https://doi.org/10.5599/admet.2603 s. ishida et al	PERSON
admet-2603	128	7	13(1	CARDINAL
admet-2603	128	8	2025	CARDINAL
admet-2603	128	9	6	CARDINAL
admet-2603	128	10	6	CARDINAL
admet-2603	133	1	6	CARDINAL
admet-2603	138	1	6.5	CARDINAL
admet-2603	140	1	32,33	CARDINAL
admet-2603	141	1	32	CARDINAL
admet-2603	144	1	0.99	CARDINAL
admet-2603	147	1	34	CARDINAL
admet-2603	149	1	four	CARDINAL
admet-2603	149	2	20	CARDINAL
admet-2603	149	3	6.05	CARDINAL
admet-2603	149	4	9.79	CARDINAL
admet-2603	149	5	1.94	CARDINAL
admet-2603	149	6	6.69	CARDINAL
admet-2603	149	7	11.61	CARDINAL
admet-2603	149	8	37 °	QUANTITY
admet-2603	150	1	20	CARDINAL
admet-2603	150	2	3	CARDINAL
admet-2603	150	3	pka van slyke	PERSON
admet-2603	150	4	31	CARDINAL
admet-2603	150	5	4.9	CARDINAL
admet-2603	150	6	4.1	CARDINAL
admet-2603	150	7	10 mm	QUANTITY
admet-2603	150	8	8.0 mm	QUANTITY
admet-2603	151	1	10 mm	QUANTITY
admet-2603	151	2	6.5	CARDINAL
admet-2603	151	3	4.6	CARDINAL
admet-2603	151	4	4.5	CARDINAL
admet-2603	151	5	19	CARDINAL
admet-2603	152	1	35	CARDINAL
admet-2603	154	1	13(1	CARDINAL
admet-2603	154	2	2025	CARDINAL
admet-2603	154	3	2603	CARDINAL
admet-2603	154	4	https://doi.org/10.5599/admet.2603 7	PERSON
admet-2603	154	5	μflux	GPE
admet-2603	155	1	first	ORDINAL
admet-2603	158	1	shiori ishida	PERSON
admet-2603	159	1	samuel lee	PERSON
admet-2603	159	2	balint sinko	PERSON
admet-2603	159	3	karl	PERSON
admet-2603	160	1	kiyohiko sugano	PERSON
admet-2603	163	1	1	CARDINAL
admet-2603	163	2	g.l. amidon	PERSON
admet-2603	163	3	g.e. amidon	PERSON
admet-2603	165	1	7 (2010) 1388-1405	DATE
admet-2603	167	1	2	CARDINAL
admet-2603	167	2	m. vertzoni	PERSON
admet-2603	167	3	j. dressman	PERSON
admet-2603	169	1	37	CARDINAL
admet-2603	169	2	2020	DATE
admet-2603	169	3	42	DATE
admet-2603	171	1	3	CARDINAL
admet-2603	171	2	silva	PERSON
admet-2603	171	3	j. al-gousous	PERSON
admet-2603	171	4	n.m. davies	PERSON
admet-2603	171	5	n.b.	GPE
admet-2603	171	6	g.k. webster	GPE
admet-2603	171	7	e. lipka	PERSON
admet-2603	171	8	g. amidon	PERSON
admet-2603	171	9	r. löbenberg	PERSON
admet-2603	173	1	european journal of pharmaceutics	ORG
admet-2603	173	2	biopharmaceutics	ORG
admet-2603	173	3	142	CARDINAL
admet-2603	173	4	2019	CARDINAL
admet-2603	174	1	4	CARDINAL
admet-2603	174	2	r.s. brickl	PERSON
admet-2603	174	3	j. dressman	PERSON
admet-2603	174	4	59	CARDINAL
admet-2603	174	5	2010	DATE
admet-2603	175	1	5	CARDINAL
admet-2603	175	2	d.p. mcnamara	GPE
admet-2603	175	3	s.l. goss	PERSON
admet-2603	177	1	20	CARDINAL
admet-2603	177	2	2003	DATE
admet-2603	177	3	1641-1646	DATE
admet-2603	179	1	6	CARDINAL
admet-2603	179	2	h.a.	GPE
admet-2603	179	3	arafat	PERSON
admet-2603	179	4	a.w. basit	PERSON
admet-2603	181	1	international journal of pharmaceutics	ORG
admet-2603	181	2	382	CARDINAL
admet-2603	181	3	2009	DATE
admet-2603	182	1	g. garbacz	PERSON
admet-2603	182	2	b. kołodziej	PERSON
admet-2603	182	3	m. koziolek	PERSON
admet-2603	182	4	w. weitschies	PERSON
admet-2603	182	5	s. klein	PERSON
admet-2603	184	1	14 (2013	DATE
admet-2603	184	2	517	CARDINAL
admet-2603	185	1	8	CARDINAL
admet-2603	185	2	n. scott	PERSON
admet-2603	185	3	k. patel	PERSON
admet-2603	185	4	k. xenofontos	PERSON
admet-2603	185	5	v. mohylyuk	PERSON
admet-2603	185	6	f. liu	PERSON
admet-2603	187	1	international journal of pharmaceutics	ORG
admet-2603	187	2	585	CARDINAL
admet-2603	187	3	2020	DATE
admet-2603	188	1	9	CARDINAL
admet-2603	188	2	a. sakamoto	PERSON
admet-2603	188	3	k. izutsu	PERSON
admet-2603	188	4	h. yoshida	PERSON
admet-2603	188	5	y. abe	PERSON
admet-2603	188	6	d. inoue	PERSON
admet-2603	188	7	k. sugano	PERSON
admet-2603	190	1	journal of drug delivery science and technology	ORG
admet-2603	190	2	63	CARDINAL
admet-2603	190	3	2021	CARDINAL
admet-2603	190	4	102447	DATE
admet-2603	191	1	https://doi.org/10.1016/j.jddst.2021.102447	ORG
admet-2603	191	2	10	CARDINAL
admet-2603	191	3	a. sakamoto	PERSON
admet-2603	191	4	k. sugano	PERSON
admet-2603	193	1	38	CARDINAL
admet-2603	193	2	2021	CARDINAL
admet-2603	195	1	11	CARDINAL
admet-2603	195	2	s. ikuta	PERSON
admet-2603	195	3	h. nakagawa	PERSON
admet-2603	195	4	t. kai	PERSON
admet-2603	195	5	k. sugano	PERSON
admet-2603	197	1	https://doi.org/10.5599/admet.2603 https://doi.org/10.1021/mp100149j https://doi.org/10.1007/s11095-019-2731-3 https://doi.org/10.1016/j.ejpb.2019.06.006	PERSON
admet-2603	197	2	https://doi.org/10.1016/j.jddst.2021.102447	NORP
admet-2603	197	3	s. ishida et al	PERSON
admet-2603	197	4	13(1	CARDINAL
admet-2603	197	5	2025	CARDINAL
admet-2603	197	6	2603	CARDINAL
admet-2603	198	1	8	CARDINAL
admet-2603	198	2	european journal of pharmaceutical sciences	ORG
admet-2603	198	3	180	CARDINAL
admet-2603	198	4	2023	CARDINAL
admet-2603	198	5	106326	DATE
admet-2603	199	1	12	CARDINAL
admet-2603	199	2	j. al-gousous	PERSON
admet-2603	199	3	g.e. amidon	GPE
admet-2603	199	4	r.m. ziff	PERSON
admet-2603	199	5	g.l. amidon	GPE
admet-2603	201	1	16	CARDINAL
admet-2603	201	2	2019	CARDINAL
admet-2603	201	3	2626-2635	CARDINAL
admet-2603	203	1	13	CARDINAL
admet-2603	203	2	krieg	GPE
admet-2603	203	3	s.m.	GPE
admet-2603	203	4	g.l. amidon	GPE
admet-2603	203	5	g.e. amidon	PERSON
admet-2603	205	1	104	CARDINAL
admet-2603	205	2	2015	CARDINAL
admet-2603	205	3	2894-2904	DATE
admet-2603	206	1	14	CARDINAL
admet-2603	206	2	d.p. mcnamara	GPE
admet-2603	206	3	g.l. amidon	GPE
admet-2603	208	1	6	CARDINAL
admet-2603	208	2	2009	DATE
admet-2603	208	3	29	CARDINAL
admet-2603	208	4	https://doi.org/10.1021/mp800148u	ORG
admet-2603	209	1	15	CARDINAL
admet-2603	209	2	k. krollik	PERSON
admet-2603	209	3	a. lehmann	PERSON
admet-2603	209	4	c. wagner	PERSON
admet-2603	209	5	j. kaidas	PERSON
admet-2603	209	6	h. kubas	PERSON
admet-2603	209	7	w. weitschies	PERSON
admet-2603	211	1	european journal of pharmaceutics	ORG
admet-2603	211	2	biopharmaceutics	ORG
admet-2603	211	3	171	CARDINAL
admet-2603	211	4	2022	CARDINAL
admet-2603	211	5	90	CARDINAL
admet-2603	211	6	16	CARDINAL
admet-2603	211	7	a. sakamoto	PERSON
admet-2603	211	8	k. sugano	PERSON
admet-2603	213	1	40	CARDINAL
admet-2603	213	2	2023	CARDINAL
admet-2603	213	3	989	CARDINAL
admet-2603	215	1	17	CARDINAL
admet-2603	215	2	h. yamamoto	PERSON
admet-2603	215	3	k. sugano	PERSON
admet-2603	217	1	21	DATE
admet-2603	217	2	2024) 28542864	DATE
admet-2603	218	1	18	CARDINAL
admet-2603	218	2	j. al-gousous	PERSON
admet-2603	218	3	k.x. sun	GPE
admet-2603	218	4	d.p.	GPE
admet-2603	218	5	mcnamara	GPE
admet-2603	218	6	m. bermejo	PERSON
admet-2603	218	7	g.e. amidon	PERSON
admet-2603	218	8	g.l. amidon	GPE
admet-2603	220	1	15	CARDINAL
admet-2603	222	1	19	CARDINAL
admet-2603	222	2	k. sugano	PERSON
admet-2603	224	1	114	CARDINAL
admet-2603	224	2	2025	CARDINAL
admet-2603	224	3	477	CARDINAL
admet-2603	225	1	20	CARDINAL
admet-2603	226	1	second	ORDINAL
admet-2603	226	2	john wiley & sons, inc.	ORG
admet-2603	226	3	2012	DATE
admet-2603	227	1	978	CARDINAL
admet-2603	227	2	21	CARDINAL
admet-2603	227	3	k. fujimoto	PERSON
admet-2603	227	4	k. wada	PERSON
admet-2603	227	5	k. sugano	PERSON
admet-2603	229	1	51	CARDINAL
admet-2603	229	2	2023) 100519	DATE
admet-2603	230	1	22	CARDINAL
admet-2603	230	2	n. okamoto	PERSON
admet-2603	230	3	m. higashino	PERSON
admet-2603	230	4	h. yamamoto	PERSON
admet-2603	230	5	k. sugano	PERSON
admet-2603	232	1	41	CARDINAL
admet-2603	232	2	2024	CARDINAL
admet-2603	232	3	959	CARDINAL
admet-2603	234	1	23	CARDINAL
admet-2603	234	2	s. ikuta	PERSON
admet-2603	234	3	h. nakagawa	PERSON
admet-2603	234	4	t. kai	PERSON
admet-2603	234	5	k. sugano	PERSON
admet-2603	236	1	european journal of pharmaceutical sciences	ORG
admet-2603	236	2	192	CARDINAL
admet-2603	236	3	2024) 106622	DATE
admet-2603	237	1	https://doi.org/10.1016/j.ejps.2023.106622	CARDINAL
admet-2603	237	2	24	CARDINAL
admet-2603	237	3	m. higashino	PERSON
admet-2603	237	4	k. sugano	PERSON
admet-2603	239	1	72	DATE
admet-2603	239	2	2024	CARDINAL
admet-2603	239	3	298	CARDINAL
admet-2603	240	1	25	CARDINAL
admet-2603	240	2	m. higashino	PERSON
admet-2603	240	3	k. sugano	PERSON
admet-2603	242	1	72	DATE
admet-2603	242	2	2024	CARDINAL
admet-2603	242	3	989	CARDINAL
admet-2603	244	1	26	CARDINAL
admet-2603	244	2	m. kansy	PERSON
admet-2603	244	3	f. senner	PERSON
admet-2603	244	4	k. gubernator	PERSON
admet-2603	246	1	journal of medicinal chemistry	ORG
admet-2603	246	2	41	CARDINAL
admet-2603	246	3	1998	DATE
admet-2603	246	4	1007-1010	DATE
admet-2603	248	1	13(1	CARDINAL
admet-2603	248	2	2025	CARDINAL
admet-2603	248	3	2603	CARDINAL
admet-2603	248	4	9	CARDINAL
admet-2603	248	5	27	CARDINAL
admet-2603	248	6	k. sugano	PERSON
admet-2603	248	7	m. kansy	PERSON
admet-2603	248	8	p. artursson	PERSON
admet-2603	248	9	a. avdeef	PERSON
admet-2603	248	10	s. bendels	PERSON
admet-2603	248	11	l. di	PERSON
admet-2603	248	12	g.f. ecker	ORG
admet-2603	248	13	b. faller	PERSON
admet-2603	248	14	h. fischer	PERSON
admet-2603	248	15	g. gerebtzoff	PERSON
admet-2603	248	16	h. lennernaes	PERSON
admet-2603	248	17	f. senner	PERSON
admet-2603	250	1	9	CARDINAL
admet-2603	250	2	2010	DATE
admet-2603	250	3	597	CARDINAL
admet-2603	251	1	28	CARDINAL
admet-2603	251	2	n. sun, a. avdeef	PERSON
admet-2603	252	1	biorelevant pk	PERSON
admet-2603	252	2	37°	QUANTITY
admet-2603	252	3	2d	DATE
admet-2603	252	4	25°	QUANTITY
admet-2603	253	1	56	CARDINAL
admet-2603	253	2	2011	DATE
admet-2603	253	3	173	CARDINAL
admet-2603	254	1	29	CARDINAL
admet-2603	255	1	leakiness	ORG
admet-2603	256	1	27	CARDINAL
admet-2603	256	2	2010	DATE
admet-2603	256	3	480	CARDINAL
admet-2603	258	1	30	CARDINAL
admet-2603	258	2	s. yamauchi	PERSON
admet-2603	258	3	k. sugano	PERSON
admet-2603	260	1	7	CARDINAL
admet-2603	260	2	2019	CARDINAL
admet-2603	260	3	151	CARDINAL
admet-2603	261	1	31	CARDINAL
admet-2603	261	2	urbansky	PERSON
admet-2603	261	3	m.r. schock.	ORG
admet-2603	263	1	77	CARDINAL
admet-2603	263	2	2009	DATE
admet-2603	263	3	1640	DATE
admet-2603	265	1	32	CARDINAL
admet-2603	265	2	k. sugano	PERSON
admet-2603	265	3	m. machida	PERSON
admet-2603	265	4	y. asoh	ORG
admet-2603	267	1	international journal of pharmaceutics	ORG
admet-2603	267	2	275	CARDINAL
admet-2603	267	3	2004	DATE
admet-2603	267	4	271	CARDINAL
admet-2603	269	1	33	CARDINAL
admet-2603	269	2	z.s. teksin	ORG
admet-2603	269	3	k. hom,	PERSON
admet-2603	269	4	a. balakrishnan	PERSON
admet-2603	269	5	j.e. polli	PERSON
admet-2603	270	1	three	CARDINAL
admet-2603	271	1	116	CARDINAL
admet-2603	271	2	2006	DATE
admet-2603	271	3	50-57	CARDINAL
admet-2603	272	1	34	CARDINAL
admet-2603	272	2	y.f.	GPE
admet-2603	272	3	shiau	PERSON
admet-2603	272	4	p. fernandez	PERSON
admet-2603	272	5	m.j. jackson	PERSON
admet-2603	272	6	s. mcmonagle	PERSON
admet-2603	274	1	american journal of physiology-gastrointestinal	ORG
admet-2603	274	2	248	CARDINAL
admet-2603	274	3	1985	DATE
admet-2603	276	1	35	CARDINAL
admet-2603	276	2	mooney	PERSON
admet-2603	276	3	m.a.	GPE
admet-2603	276	4	k.j. himmelstein	PERSON
admet-2603	276	5	v.j. stella	PERSON
admet-2603	278	1	70	CARDINAL
admet-2603	278	2	1981	DATE
admet-2603	278	3	22	CARDINAL
admet-2603	280	1	36	CARDINAL
admet-2603	280	2	b.o.	GPE
admet-2603	280	3	palsson	GPE
admet-2603	281	1	j.b.	PERSON
admet-2603	281	2	dressman	PERSON
admet-2603	283	1	5	CARDINAL
admet-2603	283	2	1988	DATE
admet-2603	283	3	272	CARDINAL
admet-2603	285	1	37	CARDINAL
admet-2603	285	2	o. tsinman	PERSON
admet-2603	287	1	25	CARDINAL
admet-2603	287	2	2613	CARDINAL
admet-2603	289	1	2025	CARDINAL
admet-2603	289	2	iapc	ORG
admet-2603	289	3	zagreb	GPE
admet-2603	289	4	croatia	GPE
admet-2603	290	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-2603	290	2	https://doi.org/10.5599/admet.2603 https://doi.org/10.1038/nrd3187	PERSON
admet-2603	291	1	http://creativecommons.org/licenses/by/3.0/	ORG